Evidence map›Paper›PMID 34283310›Full record

ReviewAmino acids2021

Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy.

Yating Liu, Chao Mao, Shuang Liu, Desheng Xiao, Ying Shi, Yongguang Tao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Amino acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. CoQExperimental & molecular medicine · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Targeting amino acid in tumor therapy.Frontiers in oncology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Yating LiuPostdoctoral Research Station of Clinical Medicine & Department of Hematology and Critical Care Medicine, Central South University, the 3rd Xiangya Hospital, Changsha, 410000, People's Republic of China.
Chao MaoDepartment of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, 410078, China.
Shuang LiuDepartment of Oncology, Institute of Medical Sciences, Center for Geriatric Disorders, National Clinical Research, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Desheng XiaoDepartment of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, 410078, China. xdsh96@csu.edu.cn.
Ying ShiDepartment of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, 410078, China. yingshi@csu.edu.cn.
Yongguang TaoDepartment of Pathology, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Xiangya Hospital, Central South University, Hunan, 410078, China. taoyong@csu.edu.cn.ORCID http://orcid.org/0000-0003-2354-5321
Central South University · CN

Funding

Hunan Provincial Key Area R&D Program 2019SK2253National Natural Science Foundation of China 81872285National Natural Science Foundation of China 81874139National Natural Science Foundation of China 82002916National Natural Science Foundation of China 82072594National Natural Science Foundation of China 82073097National Natural Science Foundation of China 82073136Natural Science Foundation of Hunan Province 2020JJ5790Postdoctoral Research Foundation of China 2019M652804Postdoctoral Science Foundation of Central South University 220372Shenzhen Municipal Government of China JCYJ20180507184647104Shenzhen Science and Technology Program KQTD20170810160226082
6 · The paper itself

Abstract

L-proline catabolism is emerging as a key pathway that is critical to cellular metabolism, growth, survival, and death. Proline dehydrogenase (PRODH) enzyme, which catalyzes the first step of proline catabolism, has diverse functional roles in regulating many pathophysiological processes, including apoptosis, autophagy, cell senescence, and cancer metastasis. Notably, accumulated evidence demonstrated that PRODH plays complex role in many types of cancers. In this review, we briefly introduce the function of PRODH, then its expression in different types of cancer. We next discuss the regulation of PRODH in cancer, the downstream pathways of PRODH and the therapies that are under investigation. Finally, we propose novel insights for future perspectives on the modulation of PRODH.

Indexed as

AnimalsApoptosisAutophagyCellular SenescenceHumansNeoplasmsProlineProline OxidaseSignal TransductionProlineProline OxidaseApoptosisAutophagyCancerL-prolinep53PRODH

Identifiers

PMID34283310
OpenAlexW3183786654

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.